We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+1.88%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$741M
AUM Growth
+$6.19M
Cap. Flow
-$3.65M
Cap. Flow %
-0.49%
Top 10 Hldgs %
17.38%
Holding
383
New
100
Increased
54
Reduced
135
Closed
78

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$21.2M
2
TJX icon
TJX Companies
TJX
+$19.9M
3
VFC icon
VF Corp
VFC
+$8.2M
4
NWL icon
Newell Brands
NWL
+$6.68M
5
MDT icon
Medtronic
MDT
+$6.38M

Sector Composition

Rank Sector Weight
1 Financials 17.29%
2 Technology 13.99%
3 Healthcare 13.29%
4 Industrials 10.17%
5 Consumer Discretionary 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CF icon
76
CF Industries
CF
$17.3B
$3.73M 0.5%
127,049
-11,915
-9% -$389K
CFG icon
77
Citizens Financial Group
CFG
$30.6B
$3.65M 0.49%
105,653
-2,713
-3% -$99K
QRVO icon
78
Qorvo
QRVO
$8.74B
$3.6M 0.49%
52,478
-1,309
-2% -$84.1K
HRL icon
79
Hormel Foods
HRL
$13.8B
$3.59M 0.48%
+103,580
New +$3.7M
RHI icon
80
Robert Half
RHI
$4.37B
$3.56M 0.48%
72,897
-19,249
-21% -$930K
XRX icon
81
Xerox
XRX
$425M
$3.5M 0.47%
119,220
+7,422
+7% +$214K
FTV icon
82
Fortive
FTV
$18.6B
$3.45M 0.47%
90,961
-2,372
-3% -$85.1K
TXMD icon
83
TherapeuticsMD
TXMD
$24M
$3.37M 0.45%
9,349
-953
-9% -$295K
BMY icon
84
Bristol-Myers Squibb
BMY
$132B
$3.3M 0.45%
60,726
+54,557
+884% +$2.99M
AXP icon
85
American Express
AXP
$230B
$3.19M 0.43%
+40,323
New +$3.15M
VNO icon
86
Vornado Realty Trust
VNO
$7.38B
$3.17M 0.43%
+39,114
New +$3.34M
TGTX icon
87
TG Therapeutics
TGTX
$7.62B
$3.07M 0.41%
263,730
-25,614
-9% -$184K
TXT icon
88
Textron
TXT
$15.4B
$3.02M 0.41%
63,564
-1,594
-2% -$76.9K
HOLX
89
DELISTED
Hologic
HOLX
$3.02M 0.41%
70,914
AET
90
DELISTED
Aetna Inc
AET
$2.89M 0.39%
22,663
-461
-2% -$57.9K
KSU
91
DELISTED
Kansas City Southern
KSU
$2.87M 0.39%
33,476
-11,064
-25% -$948K
GLPI icon
92
Gaming and Leisure Properties
GLPI
$12.8B
$2.73M 0.37%
81,789
+30,508
+59% +$963K
IQV icon
93
IQVIA
IQV
$39.3B
$2.73M 0.37%
+33,903
New +$2.65M
SEE
94
DELISTED
Sealed Air
SEE
$2.73M 0.37%
+62,604
New +$2.94M
STX icon
95
Seagate
STX
$184B
$2.72M 0.37%
59,151
-66,757
-53% -$2.96M
NBL
96
DELISTED
Noble Energy, Inc.
NBL
$2.69M 0.36%
78,344
-1,963
-2% -$72.7K
ANDV
97
DELISTED
Andeavor
ANDV
$2.68M 0.36%
33,049
-841
-2% -$70.5K
AES icon
98
AES
AES
$10.5B
$2.65M 0.36%
+237,312
New +$2.71M
MU icon
99
Micron Technology
MU
$991B
$2.63M 0.35%
90,937
-50,430
-36% -$1.23M
SNN icon
100
Smith & Nephew
SNN
$12.6B
$2.61M 0.35%
84,435
-2,236
-3% -$68.4K

Similar funds

Stoneridge Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Stoneridge Investment Partners held 383 positions worth $741M, up 0.84% from $735M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stoneridge Investment Partners's Q1 2017 filing shows 100 new, 54 increased, 135 reduced and 78 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 474,007 shares worth $15.1M. The largest sale was Abbott, an estimated $21.2M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Stoneridge Investment Partners's largest Q1 2017 buy was Twenty-First Century Fox, Inc. Class B: 474,007 shares worth $15.1M.
  • Stoneridge Investment Partners added most to Target in Q1 2017, an estimated $11M increase.
  • Stoneridge Investment Partners's biggest Q1 2017 reduction was Viatris, cutting an estimated $5.69M.
  • Stoneridge Investment Partners fully exited Abbott in Q1 2017, selling an estimated $21.2M.
  • Stoneridge Investment Partners's ten largest holdings make up 17% of its $741M portfolio in Q1 2017.
  • Stoneridge Investment Partners opened 100 new positions and closed 78 in Q1 2017.
  • Stoneridge Investment Partners's portfolio value rose 0.84% quarter-over-quarter to $741M.

Based on Stoneridge Investment Partners's 13F filing for Q1 2017, filed 1 May 2017.